Targeted Strategies for Today's Evolving Markets

MissionIR Blog

Actinium Pharma, Inc. (ATNM) Starts Presentation at 2015 Marcum MicroCap Conference

Posted on May 28, 2015 by MissionIR

Actinium Pharmaceuticals is a biopharmaceutical company focused on developing drugs to treat cancer. ATNM develops therapies for life threatening diseases using its alpha particle immunotherapy platform. Its product line-up lists Actimab-A and Iomab-B, currently in preparation for a phase 3 multicenter clinical trial for bone marrow conditioning for HSCT in relapsed and refractory AML patients. Founded in 2000, the company is based in New York City. For more information visit the company website at www.actiniumpharma.com

The Marcum MicroCap Conference is a forum where publicly traded companies with less than $500 million in market capitalization can network with the investment community. The two-day 2016 conference will include feature presentations by CEOs and CFOs from seven principal industry sectors, expert panels moderated by industry leaders, and the opportunity to meet with management of presenting companies on a one-on-one basis. Marcum is partnered with KCSA Strategic Communications to present this year's Marcum MicroCap Conference.
This entry was posted in Marcum MicroCap. Bookmark the permalink.

Comments are closed.